Death, autoantigen modifications, and tolerance

Arthritis Research

Volumn 2, Issue 2, 2000, Pages 101-114

  Utz, Paul J ^a   Gensler, Timothy J ^b   Anderson, Paul ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apoptosis; Autoantibody; Autoimmunity; Modification; Tolerance

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CASPASE; DNA ANTIBODY; LIPID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEIC ACID; PROTEIN; PROTEINASE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; BIOCHEMISTRY; CELL DEATH; CELL GRANULE; CYTOTOXIC T LYMPHOCYTE; DNA CLEAVAGE; HUMAN; IMMUNOLOGICAL TOLERANCE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RNA DEGRADATION; SCLERODERMA; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

ANIMALS; APOPTOSIS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CASPASES; HUMANS; RNA;

EID: 0034469907     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar75     Document Type: Review

References (118)

1. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease
2. Posttranslational modifications, apoptosis, and bypass of tolerance to autoantigens
3. Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE
4. The role of apoptosis in autoimmunity:immunogen, antigen, and accelerant
5. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome
6. Immunopathogenesis of SLE
7. Apoptosis and autoimmune disease
8. Autoimmunity and apoptosis
9. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured keratinocytes
10. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation
11. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
12. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on cultured keratinocytes
13. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
14. Novel packages of viral and self-antigens are generated during apoptosis
15. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes
16. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming
17. Caspase-dependent cleavage of nucleic acids
18. Autoantibodies in the diagnosis of systemic rheumatic diseases
19. Endogenous circulating DNA in systemic lupus erythematosus. Occurence as multimeric complexes bound to histone
20. Induction and natural occurence of serum nucleosomal DNA in autoimmune MRL/Ipr/Ipr mice: Its relation to apoptosis in the thymus
21. The spontaneous apoptotic cell death of normal human lymphocytes in vitro: The release of, and immunoproliferative response to, nucleosomes in vitro
22. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
23. Rheumatic aspects of acquired immunodeficiency syndrome
24. Apoptosis in serum of patients with solid tumours
25. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma
26. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens
27. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F
28. Antigens recognized by autologous antibody in patients with renal-cell carcinoma
29. Isolation and characterization of apoptotic nucleosomes, free and complexed with lupus autoantibody generated during hybridoma B-cell apoptosis
30. Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis
31. Apoptosis induced by methylazoxymethanol in developing rat cerebellum: Organization of the cell nucleus and its relationship to DNA and rRNA degradation
32. 16S mitochondrial ribosomal RNA degradation is associated with apoptosis
33. The 72 kDa component of the signal recognition particle is cleaved during apoptosis
34. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3
35. Nucleolytic degradation of the small cytoplasmic Y RNAs during apoptosis
36. The fate of the U1 small nuclear RNP complex during anti-Fas induced apoptosis: Specific cleavage of the U1 snRNA molecule
37. Caspases: Killer proteases
38. Specific cleavage of the 70 kDa protein component of the U1 small nuclear riboprotein is a characteristic biochemical feature of apoptotic cell death
39. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
40. Selective cleavage of nuclear autoantigens during CD95 (Fas/Apo-1)-mediated T cell apoptosis
41. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus
42. Association of phosphorylated SR proteins and the U1-small nuclear ribonuclear protein autoantigen complex accompanies apoptotic cell death
43. The superfamily of arginine/serine-rich splicing factors
44. A serine kinase regulates intracellular localization of splicing factors in the cell cycle
45. Purification and characterization of a serine kinase specific for the serine- and arginine-rich pre-mRNA splicing factors
46. SRPK2: A differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells
47. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors
48. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I
49. Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis
50. Phosphorylation of RNA polymerase I augments its interaction with autoantibodies of systemic lupus erythematosus patients
51. Cleavage by granzyme B is strongly predictive of autoantigen status. Implications for initiation of autoimmunity
52. T cells discriminate between differentially phosphorylated forms of alpha B-crystallin, a major central nervous system myelin antigen
53. Phosphorylation of alpha B-crystallin in response to various types of stress
54. The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis
55. Caspase-mediated activation of PAK2 during apoptosis: Proteolytic kinase activation as a general mechanism of apoptotic signal transduction
56. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis
57. Transient Poly(ADP-ribosyl)ation of nuclear proteins and role of Poly(ADP-ribose) polymerase in the early stages of apoptosis
58. Tissue transglutaminase: Apoptosis versus autoimmunity
59. Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation
60. Tissue transglutaminase antibodies in celiac disease
61. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
62. Disappearance of ubiquitinated histone H2A during chromatin condensation in TGFβ1-induced apoptosis
63. Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB X NZW and MRL-Ipr/Ipr mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice
64. Induction of ubiquitin conjugating enzyme activity for degradation of topoisomerase II alpha during adenovirus E1A-induced apoptosis
65. Antiubiquitin antibody in localised and systemic scleroderma
66. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
67. Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages
68. Deimination of 70-kD nuclear protein during epidermal apoptotic events in vitro
69. Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis
70. Granzyme A binding to target cell proteins. Granzyme A binds to and cleaves nucleolin in vitro
71. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: Implications for pathogenesis
72. Anti-fibrillarin antibodies in mercury treated mice
73. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains
74. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity
75. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties
76. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes
77. The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation
78. A cellular protein that binds to the 5′-noncoding region of poliovirus RNA: Implications for internal translation initiation
79. Direct interactions between autoantigen La and human immunodeficiency virus leader RNA
80. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus
81. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus
82. Open reading frame P-a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA
83. The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be required for this interaction
84. Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage
85. Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease
86. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3
87. Systemic exposure to irradiated apoptotic cells induces autoantibody production
88. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
89. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36 and cross-present antigens to cytotoxic T lymphocytes
90. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
91. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
92. The role of viral infection in polymyositis, dermatomyositis and chronic fatigue syndrome
93. Cellular immune mechanisms in inflammatory myopathies
94. Self antigens and epitope spreading in systemic autoimmunity
95. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition
96. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
97. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis
98. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: Novel tools for the diagnosis of rheumatic diseases
99. Heterogeneous ribonucleo-proteins C1 and C2, components of the spliceosome, are specific targets of interleukin 1β-converting enzyme-like proteases in apoptosis
100. Identification of keratins 18, 19 and heat-shock protein 90 beta as candidate substrates of proteolysis during ionizing radiation-induced apoptosis of estrogen-receptor negative breast tumor cells
101. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis
102. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A
103. Cleavage of lamin A by Mch2 alpha but not CPP32: Multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis
104. Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action
105. Autoantibodies to nucleolin in systemic lupus erythematosus and other diseases
106. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis
107. Cleavage of Poly(ADP-ribose) polymerase by interleukin-1β converting enzyme and its homologs TX and Nedd-2
108. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
109. Human RNA helicase A is a lupus autoantigen that is cleaved during apoptosis
110. Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis
111. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus
112. Antibody to intermediate filaments of the cytoskeleton in patients with Behcet's disease
113. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases
114. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA
115. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis
116. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease
117. Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with and without insulin-dependent diabetes mellitus
118. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus patients